Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
about
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney functionAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsMeta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile NeutropeniaRecommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)Antifungal susceptibility testing: current role from the clinical laboratory perspectiveRecent developments in the management of invasive fungal infections in patients with oncohematological diseasesAntifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsPerformance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.Canadian clinical practice guidelines for invasive candidiasis in adults.The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.Treatment options in Invasive Aspergillosis.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control studyTreatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010?Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades.Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.How to treat fungal infections in ICU patients.Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year periodUniversal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approachEmpiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis.The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis.Use of antifungal drugs in hematologyNeonatal fungal infections: when to treat?Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesInvasive fungal infections in acute leukemia.Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in ChildrenComparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model.Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology PatientsImplementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaCost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.
P2860
Q24187699-8E6FACE7-2F69-4EB9-BFDD-9F099D28FA17Q24239978-038A9DF6-B905-4FA2-80E5-151FBF73CFE2Q26778187-0AAC1648-DC32-458F-BD4B-6D079E5C10FAQ26824260-06D9B486-7D4E-45DC-986E-8BE7CA5050ABQ26825753-B4AF878A-200F-43E7-A687-2346DC8132B4Q26862478-FF004B05-F784-4711-925F-EEAF99A10478Q28077381-5C8E5F13-35BA-4F10-AEE8-60541C85A747Q28080147-7B24C008-FB82-4B18-A45F-C119CB3215D8Q31120454-2E7751DC-B814-4251-86EB-44F6D599F322Q33572014-736E7834-9561-416B-A571-8CF147F16047Q33712955-AF762E93-6E73-4427-A93B-E8EBA18AF461Q34151170-774470ED-ABC0-451B-92D5-EB85D380850FQ34237335-77079526-C67C-4D42-BD09-1DEB9C545306Q34290097-5FC30D1B-2CBE-47E1-A553-F498E7E4EE9EQ34357504-2AFB2525-D68C-450E-9130-1D59715153DFQ34532546-6767FBFD-1C0B-4F18-A02C-B7D7851C3454Q34543097-DB676955-5B62-4EEB-8972-9A34E3CFF16BQ34667166-27F6C3A3-DC21-46A8-9C54-70919E789412Q35010346-F9BBD703-D798-4F51-A921-A66E8FCC34A9Q35019920-8AA4EEF2-294E-4322-91A8-3907D54DC5FAQ35033597-84374869-5DC4-46FA-86F7-BA775910F110Q35193749-57810325-CEF0-4FA9-9929-224F749342E3Q35568846-5181629F-A372-458A-91C8-DC5CD516D916Q35700698-5850E3CA-2A7C-4712-B9CF-7791BA118CFBQ35756513-C66CC84B-E920-413C-9661-C266404F6890Q35794484-AAD1A9BA-BEF0-4D8A-BCAE-9A54DDCF165BQ35794490-DD1FC2C5-907B-472A-A024-C5BC2FD52B63Q36049420-4031B325-E9B1-4A0C-B43D-50CD3D3D6D81Q36264982-4B7AE36E-81EA-4BAE-A25F-5061A53D94F4Q36364856-917BC22F-BD5F-4913-92F2-AF0C94049956Q36440830-C6473AFE-EA10-4DF2-B7D1-53680C557F45Q36456366-AF01400A-0EA3-4FE9-882D-4304D67FAC72Q36584898-09F2FEAF-1B35-4127-93EB-A49A0201B6D8Q36612597-5B2301D0-8A47-4413-BA50-A25841F7FFF6Q36620870-FF56083C-D24C-4B3C-9D78-B12F13B852F8Q36630700-472B76BE-67E7-4AFE-9D43-66AF7DD78442Q36734965-B5C60431-056E-4C18-84C4-851931417384Q36851160-48D5F554-311C-4F5B-82F1-74D783345281Q37220711-097FD0DF-38ED-4A9C-96F8-98D925182856Q37263911-90158380-CF78-4BA4-A43E-E6ABB5E4F417
P2860
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Empirical versus preemptive an ...... randomized, controlled trial.
@en
type
label
Empirical versus preemptive an ...... randomized, controlled trial.
@en
prefLabel
Empirical versus preemptive an ...... randomized, controlled trial.
@en
P2093
P356
P1476
Empirical versus preemptive an ...... a randomized, controlled trial
@en
P2093
Anne Vekhoff
Catherine Cordonnier
Cécile Pautas
Felipe Suarez
Francoise Isnard
Françoise Foulet
Frédérique Kuhnowski
Hassan Farhat
Lionel Ades
Mathieu Kuentz
P304
P356
10.1086/597395
P407
P577
2009-04-01T00:00:00Z